Status epilepticus: Difference between revisions
Jump to navigation
Jump to search
Zehra Malik (talk | contribs) |
Zehra Malik (talk | contribs) |
||
Line 31: | Line 31: | ||
*Common complications of status epilepticus include [[cardiac dysrhythmia]], metabolic derangements, [[autonomic dysfunction]], neurogenic [[pulmonary edema]], [[hyperthermia]], [[rhabdomyolysis]], and [[aspiration pneumonia]]. <ref name="SutterDittrich2018">{{cite journal|last1=Sutter|first1=Raoul|last2=Dittrich|first2=Tolga|last3=Semmlack|first3=Saskia|last4=Rüegg|first4=Stephan|last5=Marsch|first5=Stephan|last6=Kaplan|first6=Peter W.|title=Acute Systemic Complications of Convulsive Status Epilepticus—A Systematic Review|journal=Critical Care Medicine|volume=46|issue=1|year=2018|pages=138–145|issn=0090-3493|doi=10.1097/CCM.0000000000002843}}</ref> | *Common complications of status epilepticus include [[cardiac dysrhythmia]], metabolic derangements, [[autonomic dysfunction]], neurogenic [[pulmonary edema]], [[hyperthermia]], [[rhabdomyolysis]], and [[aspiration pneumonia]]. <ref name="SutterDittrich2018">{{cite journal|last1=Sutter|first1=Raoul|last2=Dittrich|first2=Tolga|last3=Semmlack|first3=Saskia|last4=Rüegg|first4=Stephan|last5=Marsch|first5=Stephan|last6=Kaplan|first6=Peter W.|title=Acute Systemic Complications of Convulsive Status Epilepticus—A Systematic Review|journal=Critical Care Medicine|volume=46|issue=1|year=2018|pages=138–145|issn=0090-3493|doi=10.1097/CCM.0000000000002843}}</ref> | ||
*Permanent [[neurologic]] damage can occur with prolonged status epilepticus. | *Permanent [[neurologic]] damage can occur with prolonged status epilepticus. | ||
*Prognosis of status epilepticus depends upon the underlying cause, age, and medical condition of the patient. Overall, status epilepticus has a 7%–39% mortality rate.<ref name="TownePellock1994">{{cite journal|last1=Towne|first1=Alan R.|last2=Pellock|first2=John M.|last3=Ko|first3=Daijin|last4=DeLorenzo|first4=Robert J.|title=Determinants of Mortality in Status Epilepticus|journal=Epilepsia|volume=35|issue=1|year=1994|pages=27–34|issn=0013-9580|doi=10.1111/j.1528-1157.1994.tb02908.x}}</ref> | |||
*Approximately 10 to 30% of patients with underlying [[brain]] condition who have status epilepticus die within 30 days.<ref name="Al-MuftiClaassen2014">{{cite journal|last1=Al-Mufti|first1=Fawaz|last2=Claassen|first2=Jan|title=Neurocritical Care|journal=Critical Care Clinics|volume=30|issue=4|year=2014|pages=751–764|issn=07490704|doi=10.1016/j.ccc.2014.06.006}}</ref> | *Approximately 10 to 30% of patients with underlying [[brain]] condition who have status epilepticus die within 30 days.<ref name="Al-MuftiClaassen2014">{{cite journal|last1=Al-Mufti|first1=Fawaz|last2=Claassen|first2=Jan|title=Neurocritical Care|journal=Critical Care Clinics|volume=30|issue=4|year=2014|pages=751–764|issn=07490704|doi=10.1016/j.ccc.2014.06.006}}</ref> | ||
*Patients with [[epilepsy]] and who develop status epilepticus have increased [[mortality]] risk. However, stabilizing condition and optimal maintenance of medication, sleep, stress factors and stimulants plays an important role in improving [[prognosis]]. <ref name="StasiukynienėPilvinis2009">{{cite journal|last1=Stasiukynienė|first1=Virginija|last2=Pilvinis|first2=Vidas|last3=Reingardienė|first3=Dagmara|last4=Janauskaitė|first4=Liuda|title=Epileptic seizures in critically ill patients|journal=Medicina|volume=45|issue=6|year=2009|pages=501|issn=1010-660X|doi=10.3390/medicina45060066}}</ref> | *Patients with [[epilepsy]] and who develop status epilepticus have increased [[mortality]] risk. However, stabilizing condition and optimal maintenance of medication, sleep, stress factors and stimulants plays an important role in improving [[prognosis]]. <ref name="StasiukynienėPilvinis2009">{{cite journal|last1=Stasiukynienė|first1=Virginija|last2=Pilvinis|first2=Vidas|last3=Reingardienė|first3=Dagmara|last4=Janauskaitė|first4=Liuda|title=Epileptic seizures in critically ill patients|journal=Medicina|volume=45|issue=6|year=2009|pages=501|issn=1010-660X|doi=10.3390/medicina45060066}}</ref> | ||
==Treatments== | ==Treatments== |
Revision as of 16:54, 14 September 2020
Resident Survival Guide |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Status epilepticus from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
- Common complications of status epilepticus include cardiac dysrhythmia, metabolic derangements, autonomic dysfunction, neurogenic pulmonary edema, hyperthermia, rhabdomyolysis, and aspiration pneumonia. [1]
- Permanent neurologic damage can occur with prolonged status epilepticus.
- Prognosis of status epilepticus depends upon the underlying cause, age, and medical condition of the patient. Overall, status epilepticus has a 7%–39% mortality rate.[2]
- Approximately 10 to 30% of patients with underlying brain condition who have status epilepticus die within 30 days.[3]
- Patients with epilepsy and who develop status epilepticus have increased mortality risk. However, stabilizing condition and optimal maintenance of medication, sleep, stress factors and stimulants plays an important role in improving prognosis. [4]
Treatments
- ↑ Sutter, Raoul; Dittrich, Tolga; Semmlack, Saskia; Rüegg, Stephan; Marsch, Stephan; Kaplan, Peter W. (2018). "Acute Systemic Complications of Convulsive Status Epilepticus—A Systematic Review". Critical Care Medicine. 46 (1): 138–145. doi:10.1097/CCM.0000000000002843. ISSN 0090-3493.
- ↑ Towne, Alan R.; Pellock, John M.; Ko, Daijin; DeLorenzo, Robert J. (1994). "Determinants of Mortality in Status Epilepticus". Epilepsia. 35 (1): 27–34. doi:10.1111/j.1528-1157.1994.tb02908.x. ISSN 0013-9580.
- ↑ Al-Mufti, Fawaz; Claassen, Jan (2014). "Neurocritical Care". Critical Care Clinics. 30 (4): 751–764. doi:10.1016/j.ccc.2014.06.006. ISSN 0749-0704.
- ↑ Stasiukynienė, Virginija; Pilvinis, Vidas; Reingardienė, Dagmara; Janauskaitė, Liuda (2009). "Epileptic seizures in critically ill patients". Medicina. 45 (6): 501. doi:10.3390/medicina45060066. ISSN 1010-660X.